Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing

In chronic myeloid leukemia, the identification of individual BCR-ABL1 fusions is required for the development of personalized medicine approach for minimal residual disease monitoring at the DNA level. Next generation sequencing (NGS) of amplicons larger than 1000 bp simplified and accelerated a pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Linhartova, Jana, Hovorkova, Lenka, Soverini, Simona, Benesova, Adela, Jaruskova, Monika, Klamova, Hana, Zuna, Jan, Machova Polakova, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409993/
https://www.ncbi.nlm.nih.gov/pubmed/25928096
http://dx.doi.org/10.1186/s12943-015-0363-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409993/
https://www.ncbi.nlm.nih.gov/pubmed/25928096
http://dx.doi.org/10.1186/s12943-015-0363-8

Ejemplares similares